SMA Lab

Stephanie shared the team’s latest findings on the discovery of potential therapies for CTNNB1 mutation-driven HCC using a genetically defined, syngeneic mouse organoid platform at this year’s SKLLR Symposium, held on October 16th, 2024, at Renaissance Harbor View Hotel HK.